neoplasm
• epidermal papillomatosis
|
• mutants develop acute promyelocytic leukemia between 3 and 9 months of age, with a median age of 174 days
• mixed hematopoiesis of normal bone marrow is completely replaced by leukemic cells, splenic and lymphatic architecture is effaced and leukemia extends throughout the hepatic parenchyma
• both preleukemic state and the leukemia can be transplanted to wild-type mice and the preleukemia progresses to acute promyelocytic leukemia
|
immune system
• impaired neutrophil maturation early in life
|
hematopoietic system
• impaired neutrophil maturation early in life
|
cardiovascular system
hemorrhage
(
J:39327
)
• some leukemic mutants hemorrhage spontaneously
|
homeostasis/metabolism
• leukemic mutants are abnormally susceptible to bleeding after injections
|
• some mutants exhibit fibrin thrombi in pulmonary blood vessels but not in other organs
|
integument
• epidermal papillomatosis
|
cellular
• impaired neutrophil maturation early in life
|
Mouse Models of Human Disease |
DO ID | OMIM ID(s) | Ref(s) | |
acute promyelocytic leukemia | DOID:0060318 |
OMIM:612376 |
J:39327 |